These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34016578)

  • 1. When technology precedes regulation: the challenges and opportunities of e-pharmacy in low-income and middle-income countries.
    Miller R; Wafula F; Onoka CA; Saligram P; Musiega A; Ogira D; Okpani I; Ejughemre U; Murthy S; Garimella S; Sanderson M; Ettelt S; Allen P; Nambiar D; Salam A; Kweyu E; Hanson K; Goodman C
    BMJ Glob Health; 2021 May; 6(5):. PubMed ID: 34016578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare clinic and pharmacy chains in Kenya and Nigeria: A qualitative exploration of the opportunities and risks they present for healthcare regulatory systems.
    Wafula F; Onoka C; Musiega A; Okpani A; Ogira D; Ejughemre U; Miller R; Goodman C; Hanson K
    Int J Health Plann Manage; 2022 Nov; 37(6):3329-3343. PubMed ID: 35983649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities.
    Kaplan WA; Cellini CM; Eghan K; Pilz K; Harrison D; Wirtz VJ
    J Pharm Policy Pract; 2023 May; 16(1):60. PubMed ID: 37131256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs).
    Babar ZU
    J Pharm Policy Pract; 2021 Jan; 14(1):6. PubMed ID: 33407945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of global e-pharmacies: can we safeguard consumers?
    Bessell TL; Silagy CA; Anderson JN; Hiller JE; Sansom LN
    Eur J Clin Pharmacol; 2002 Dec; 58(9):567-72. PubMed ID: 12483449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating pharmacists as contraception providers: A qualitative study from Coastal Kenya on injectable contraception provision to youth.
    Gonsalves L; Wyss K; Gichangi P; Say L; Martin Hilber A
    PLoS One; 2019; 14(12):e0226133. PubMed ID: 31856196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria.
    Amadi C; Tsui EK
    Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solving the problem of access to cardiovascular medicines: revolving fund pharmacy models in rural western Kenya.
    Tran DN; Manji I; Njuguna B; Kamano J; Laktabai J; Tonui E; Vedanthan R; Pastakia S
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33214173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries.
    Roth L; Nalim A; Turesson B; Krech L
    Global Health; 2018 Apr; 14(1):43. PubMed ID: 29695278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.
    Flood D; Mathieu I; Chary A; García P; Rohloff P
    BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and behaviors regarding online pharmacies in the aftermath of COVID-19 pandemic: At the tipping point towards the new normal.
    Fittler A; Ambrus T; Serefko A; Smejkalová L; Kijewska A; Szopa A; Káplár M
    Front Pharmacol; 2022; 13():1070473. PubMed ID: 36642991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance.
    Redfern J; Kaur H; Adedoyin RA; Ofori S; Anchala R; Vamadevan AS; De Andrade L; Zelaya J; Balabanova D; Sani MU
    Glob Heart; 2019 Sep; 14(3):327-333. PubMed ID: 31451241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supply-chain strategies for essential medicines in rural western Kenya during COVID-19.
    Tran DN; Were PM; Kangogo K; Amisi JA; Manji I; Pastakia SD; Vedanthan R
    Bull World Health Organ; 2021 May; 99(5):388-392. PubMed ID: 33958827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matching safety to access: global actors and pharmacogovernance in Kenya- a case study.
    Moscou K; Kohler JC
    Global Health; 2017 Mar; 13(1):20. PubMed ID: 28335786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.